Risk factors for clinically important adverse events after protamine administration following cardiopulmonary bypass
- 1 December 1998
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 32 (7) , 1916-1922
- https://doi.org/10.1016/s0735-1097(98)00484-7
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Five year trends in cardiac catheterization: A report from the registry of the society for cardiac angiography and interventionsCatheterization and Cardiovascular Diagnosis, 1996
- Differential effects of protamine sulfate on myocyte contractile function with left ventricular failureJournal of the American College of Cardiology, 1995
- Immunologic analysis of anaphylaxis to protamine component in neutral protamine Hagedorn human insulinJournal of Allergy and Clinical Immunology, 1994
- High-titer Protamine-specific IgG Antibody Associated with AnaphylaxisAnesthesiology, 1993
- A prospective study of the risk of an immediate adverse reaction to protamine sulfate during cardiopulmonary bypass surgeryJournal of Allergy and Clinical Immunology, 1990
- Association of Protamine IgE and IgG Antibodies with Life-Threatening Reactions to Intravenous ProtamineNew England Journal of Medicine, 1989
- The safety of protamine sulfate in diabetics undergoing cardiac catheterizationCatheterization and Cardiovascular Diagnosis, 1987
- Management of the Patient with Protamine Hypersensitivity for Cardiac SurgeryAnesthesiology, 1984
- Increased risk of severe protamine reactions in NPH insulin-dependent diabetics undergoing cardiac catheterization.Circulation, 1984
- An Anaphylactic Reaction to Protamine in a Patient Allergic to FishAnesthesiology, 1981